Search

Investment Banking
Institutional Equities
Sectors
Insights
About
- Firm
- Careers
- News
- Contact
- Transactions

Terms of Use
Privacy Policy
Cookies
Notice to California Residents
Important Disclosures

Stay ahead of what’s next Client Login

CPE Newsletter

The US market-based price for Zurzuvae is worth it

Is health technology assessment the solution to our problem?

A big limitation to an approach to drug pricing used by many ex-US countries

Entresto’s Medicare negotiated price is a head scratcher

The pill penalty could reduce incentives for post-approval research

Banner desktop

Join Our Mailing List

Receive CPE newsletters, reports, and correspondence in your inbox

CPE Contact

Complete the form below to get added to our mailing list. Our team looks forward to connecting with you. “*” indicates required fields

First Name(Required)

Last Name(Required)

Email(Required)

Company Name(Required)

Consent(Required)

I accept the Terms

Email

This field is for validation purposes and should be left unchanged.

For Corporates
- Private Capital Markets
For Investors
Sectors
Insights
About
- Firm
- Careers
- News
- Contact
- Transactions

Member FINRA/SIPC
Terms of Use
Privacy Policy
Cookies
Notice to California Residents
Important Disclosures